Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Walters, Lucy C."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-7 z 7
    Tytuł:
    Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.
    Autorzy:
    Hansen SG; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Wu HL; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Burwitz BJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Hughes CM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Hammond KB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Ventura AB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Reed JS; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Gilbride RM; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Ainslie E; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Morrow DW; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Ford JC; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Selseth AN; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Pathak R; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Malouli D; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Legasse AW; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Axthelm MK; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Nelson JA; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Gillespie GM; Nuffield Department of Medicine, University of Oxford, Oxford OX37FZ, UK.
    Walters LC; Nuffield Department of Medicine, University of Oxford, Oxford OX37FZ, UK.
    Brackenridge S; Nuffield Department of Medicine, University of Oxford, Oxford OX37FZ, UK.
    Sharpe HR; Nuffield Department of Medicine, University of Oxford, Oxford OX37FZ, UK.
    López CA; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
    Früh K; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Korber BT; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM 87545, USA. The New Mexico Consortium, Los Alamos, NM 87545, USA.
    McMichael AJ; Nuffield Department of Medicine, University of Oxford, Oxford OX37FZ, UK.
    Gnanakaran S; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM 87545, USA.
    Sacha JB; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Picker LJ; Vaccine and Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR 97006, USA.
    Pokaż więcej
    Źródło:
    Science (New York, N.Y.) [Science] 2016 Feb 12; Vol. 351 (6274), pp. 714-20. Date of Electronic Publication: 2016 Jan 21.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    CD8-Positive T-Lymphocytes/*immunology
    Cytomegalovirus/*immunology
    Epitopes, T-Lymphocyte/*immunology
    Histocompatibility Antigens Class I/*immunology
    Simian Immunodeficiency Virus/*immunology
    Animals ; Antigen Presentation ; Antigenic Variation ; Cytomegalovirus/genetics ; Epitopes, T-Lymphocyte/chemistry ; Genetic Vectors/genetics ; Genetic Vectors/immunology ; Histocompatibility Antigens Class I/chemistry ; Host-Pathogen Interactions/immunology ; Immune Evasion ; Killer Cells, Natural/immunology ; Macaca mulatta ; Protein Structure, Secondary ; Vaccination
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Author Correction: Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding
    Autorzy:
    Walters, Lucy C.
    Harlos, Karl
    Brackenridge, Simon
    Rozbesky, Daniel
    Barrett, Jordan R.
    Jain, Vitul
    Walter, Thomas S.
    O’Callaghan, Chris A.
    Borrow, Persephone
    Toebes, Mireille
    Hansen, Scott G.
    Sacha, Jonah B.
    Abdulhaqq, Shaheed
    Greene, Justin M.
    Früh, Klaus
    Marshall, Emily
    Picker, Louis J.
    Jones, E. Yvonne
    McMichael, Andrew J.
    Gillespie, Geraldine M.
    Pokaż więcej
    Źródło:
    Nature Communications. 9(1)
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity.
    Autorzy:
    Li D; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.
    Brackenridge S; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
    Walters LC; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
    Swanson O; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
    Harlos K; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
    Rozbesky D; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.; Department of Cell Biology, Charles University, Prague, 12800, Czech Republic.
    Cain DW; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.
    Wiehe K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.
    Scearce RM; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
    Barr M; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
    Mu Z; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
    Parks R; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.
    Quastel M; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
    Edwards RJ; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.
    Wang Y; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.
    Rountree W; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.
    Saunders KO; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.; Department of Immunology, Duke University School of Medicine, Durham, NC, 27710, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC, 27710, USA.
    Ferrari G; Department of Surgery, Duke University School of Medicine, Durham, NC, 27710, USA.
    Borrow P; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK.
    Jones EY; Division of Structural Biology, Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
    Alam SM; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA.
    Azoitei ML; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA. .; Department of Medicine, Duke University School of Medicine, Durham, NC, 27710, USA. .
    Gillespie GM; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK. .
    McMichael AJ; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7FZ, UK. .
    Haynes BF; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC, 27710, USA. .; Department of Immunology, Duke University School of Medicine, Durham, NC, 27710, USA. .
    Pokaż więcej
    Źródło:
    Communications biology [Commun Biol] 2022 Mar 28; Vol. 5 (1), pp. 271. Date of Electronic Publication: 2022 Mar 28.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Cytotoxicity, Immunologic*
    Histocompatibility Antigens Class I*/genetics
    Animals ; HLA Antigens ; Humans ; Immunoglobulins/metabolism ; Killer Cells, Natural ; Mice ; Peptides/metabolism ; Protein Sorting Signals ; HLA-E Antigens
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-7 z 7

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies